New Dietary Ingredients

Browse New Dietary Ingredients Content

Press Releases and Statements

CHPA applauds FDA's inclusion of the publication of a revised version of the New Dietary Ingredient (NDI) Draft Guidance within its priorities for 2022.

Jul 1, 2021

Article

For its annual year-in-review series, Chain Drug Review featured CHPA's President & CEO, Scott Melville, who offered industry insights from last year and thoughts on the outlook for 2021.

Jan 7, 2021

Press Releases and Statements

Today’s column in the Los Angeles Times is aligned with calls from responsible manufacturers in the dietary supplement industry who agree that regulations need to be modernized and strengthened.

Dec 15, 2020

Press Releases and Statements

The U.S. dietary supplement industry commends FDA for taking action to protect consumers by calling out marketers who make illegal and unsubstantiated drug claims related to COVID-19.

Apr 6, 2020

Submission

CHPA believes that FDA’s revised 2016 Draft Guidance is an important step in helping to improve manufacturer understanding of, and compliance with, the new dietary ingredient notification requirement in Section 413 of the Federal Food, Drug, and Cosmetic Act.

Dec 12, 2016

Submission

Echoing earlier comments submitted to the agency, CHPA and its member companies marketing dietary supplement products support the presumption of safety for dietary ingredients outlined in the 1994 passage of DSHEA.

Oct 24, 2013

Submission

We take this opportunity to voice our support of comments submitted by the Council for Responsible Nutrition (CRN) regarding the appropriate interpretation of the term “chemically altered” under Section 413(a)(1) of the Federal Food, Drug, and Cosmetic Act.

Jul 12, 2013

Submission

We take this opportunity to voice our support of comments submitted by the American Herbal Products Association regarding proposed revisions to the agency's Draft Guidance on New Dietary Ingredient Notification.

May 10, 2013

Filter Results